Cargando…

Gene Therapy with Cytosine Deaminase and Endostatin Fusion Gene Mediated by Endothelial Progenitor Cells in Hepatomas

PURPOSE: Gene-targeting therapy provides a novel therapeutic approach for tumor treatment using genetically modified endothelial progenitor cells (EPCs) as cellular carriers. This study applied EPCs armed with cytosine deaminase (CD) and endostatin (ES) fusion gene in liver cancer to explore its the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yue-Lin, Zhou, Tan-Yang, Ai, Jing, Chen, Sheng-Qun, Chen, Feng, Nie, Chun-Hui, Chen, Xin-Hua, Zhou, Guan-Hui, Wang, Hong-Liang, Zhu, Tong-Yin, Wang, Bao-Quan, Yu, Zi-Niu, Jing, Li, Wu, Li-Ming, Zheng, Shu-Sen, Sun, Jun-Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198450/ https://www.ncbi.nlm.nih.gov/pubmed/32431545 http://dx.doi.org/10.2147/CMAR.S245998

Ejemplares similares

Effects of lentivirus-mediated endostatin on endothelial progenitor cells
por: Ai, Jing, et al.
Publicado: (2017)

Generation of an anti-angiogenic endothelial progenitor cell line via endostatin gene transfer
por: Ai, Jing, et al.
Publicado: (2018)

Cytosine and adenine deaminase base-editors induce broad and nonspecific changes in gene expression and splicing
por: Fan, Jiao, et al.
Publicado: (2021)

Efficacy of gene therapy-delivered cytosine deaminase is determined by enzymatic activity but not expression
por: Dubois, L, et al.
Publicado: (2007)

Adenoviral-Mediated Imaging of Gene Transfer Using a Somatostatin Receptor-Cytosine Deaminase Fusion Protein
por: Lears, Kimberly A., et al.
Publicado: (2015)

An Endostatin-lentivirus (ES-LV)-EPC gene therapy agent for suppression of neovascularization in oxygen-induced retinopathy rat model
por: Ai, Jing, et al.
Publicado: (2020)

Adenovirus-mediated hypoxia-targeting cytosine deaminase gene therapy enhances radiotherapy in tumour xenografts
por: Liu, J, et al.
Publicado: (2007)

Retrovirus-mediated transduction of a cytosine deaminase gene preserves the stemness of mesenchymal stem cells
por: Sung Park, Jin, et al.
Publicado: (2013)

AID/APOBEC cytosine deaminase induces genome-wide kataegis
por: Lada, Artem G, et al.
Publicado: (2012)

AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation
por: Nabel, Christopher S., et al.
Publicado: (2012)

Improved cytotoxic effects of Salmonella-producing cytosine deaminase in tumour cells
por: Mesa-Pereira, Beatriz, et al.
Publicado: (2015)

Connexin-43 Enhances the Redesigned Cytosine Deaminase Activity for Suicide Gene Therapy in Human Breast Cancer Cells
por: Raza, Asif, et al.
Publicado: (2019)

Enhanced EJ Cell Killing of (125)I Radiation by Combining with Cytosine Deaminase Gene Therapy Regulated by Synthetic Radio-Responsive Promoter
por: Li, Ling, et al.
Publicado: (2015)

A dual-deaminase CRISPR base editor enables concurrent adenine and cytosine editing
por: Grünewald, Julian, et al.
Publicado: (2020)

Recombined humanized endostatin (Endostar) intravenous infusion in the treatment of refractory nasopharyngeal carcinoma: Three case reports
por: Chen, Chen, et al.
Publicado: (2019)

Antitumor efficacy of cytosine deaminase-armed vaccinia virus plus 5-fluorocytosine in colorectal cancers
por: Ding, Yuedi, et al.
Publicado: (2020)

Adenosine deaminase and adenosine kinase in rat hepatomas and kidney tumours.
por: Jackson, R. C., et al.
Publicado: (1978)

Engineering the Active Site Lid Dynamics to Improve the Catalytic Efficiency of Yeast Cytosine Deaminase
por: Deng, Hanzhong, et al.
Publicado: (2023)

Clinical effects of cisplatin plus recombinant human endostatin (rh-endostatin) intratumoral injection on malignant central airway obstruction: a retrospective analysis of 319 cases
por: Zhou, Yunzhi, et al.
Publicado: (2021)

Microbial cytosine deaminase is a programmable anticancer prodrug mediating enzyme: antibody, and gene directed enzyme prodrug therapy
por: El-Sayed, Ashraf S.A., et al.
Publicado: (2022)

Comparison of the antiangiogenic activity of modified RGDRGD-endostatin to endostatin delivered by gene transfer in vivo rabbit neovascularization model
por: Ge, Hong-yan, et al.
Publicado: (2011)

Mycoplasma hyorhinis-encoded cytidine deaminase efficiently inactivates cytosine-based anticancer drugs
por: Vande Voorde, Johan, et al.
Publicado: (2015)

Conformational Switch Regulates the DNA Cytosine Deaminase Activity of Human APOBEC3B
por: Shi, Ke, et al.
Publicado: (2017)

The DNA damage induced by the Cytosine Deaminase APOBEC3A Leads to the production of ROS
por: Niocel, Mathilde, et al.
Publicado: (2019)

Deoxycytidylate Deaminase and Thymine Catabolic Activity of Transplanted Mouse and Rat Hepatomas and their Histology
por: Emmelot, P., et al.
Publicado: (1961)

Cytosine deaminase as a negative selectable marker for the microalgal chloroplast: a strategy for the isolation of nuclear mutations that affect chloroplast gene expression
por: Young, Rosanna E B, et al.
Publicado: (2014)

Comparisons of biophysical properties and bioactivities of mono-PEGylated endostatin and an endostatin analog
por: Wang, Shan, et al.
Publicado: (2016)

Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B
por: Akre, Monica K., et al.
Publicado: (2016)

APOBEC1 cytosine deaminase activity on single-stranded DNA is suppressed by replication protein A
por: Wong, Lai, et al.
Publicado: (2020)

Dose of Adenoviral Vectors Expressing Interleukin‐2 Plays an Important Role in Combined Gene Therapy with Cytosine Deaminase/5–Fluorocytosine: Preclinical Consideration
por: Nakamori, Mikihito, et al.
Publicado: (2002)

Endostatin in the pancreas
por: Wigmore, S J
Publicado: (2005)

Inhibitory effect of endostatin gene therapy combined with phosphorus-32 colloid on tumour growth in Wistar rats
por: Gao, Huiqi, et al.
Publicado: (2016)

The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer
por: Law, Emily K., et al.
Publicado: (2016)

Human activation-induced deaminase lacks strong replicative strand bias or preference for cytosines in hairpin loops
por: Sakhtemani, Ramin, et al.
Publicado: (2022)

Structural basis of sequence-specific cytosine deamination by double-stranded DNA deaminase toxin DddA
por: Yin, Lulu, et al.
Publicado: (2023)

Real‐world outcomes of various regimens of recombinant human endostatin combined with chemotherapy in non‐driver gene mutation advanced non‐small cell lung cancer
por: Wang, Zhongtai, et al.
Publicado: (2019)

Combined BRM270 and endostatin inhibit relapse of NSCLC while suppressing lung cancer stem cell proliferation induced by endostatin
por: Gu, Yan-hui, et al.
Publicado: (2021)

Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas
por: Chung, Taemoon, et al.
Publicado: (2016)

Transcatheter embolization of hepatocellular carcinoma with epirubicin-loaded DC beads in Chinese patients
por: Zhou, Guan-Hui, et al.
Publicado: (2019)

Recombinant Human Endostatin Normalizes Tumor Vasculature and Enhances Radiation Response in Xenografted Human Nasopharyngeal Carcinoma Models
por: Peng, Fang, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n64mivr2jdfb9nc1vmc5veq8vu